Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/12/2000CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368493A1 Lta4 hydrolase inhibitors
10/12/2000CA2368367A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2368215A1 Compositions and methods for treatment of diabetes
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367294A1 Prediction of risk of interstitial lung disease
10/12/2000CA2367143A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367052A1 Use of cyp2d6 inhibitors in combination therapies
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366903A1 Methods for modulating the human sexual response
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366884A1 Enhanced tissue and subcellular delivery of vitamin e compounds
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2366850A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000CA2366807A1 Anti-tumor activity of vitamin e, cholesterol, taxol and betulinic acid derivatives
10/12/2000CA2366799A1 Propofol compositions containing preservative additives
10/12/2000CA2366791A1 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
10/12/2000CA2366787A1 Compositions and methods for treating lymphoma
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365419A1 Novel thiazolobenzoimidazole derivatives
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/12/2000CA2363942A1 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/12/2000CA2362116A1 Use of succinic acid or salts thereof for the treatment of diabetes mellitus and wound healing
10/12/2000CA2361988A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
10/12/2000CA2361885A1 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/12/2000CA2268590A1 Ion channel modulating compounds and uses thereof
10/12/2000CA2268588A1 Novel aryl-chloro-ethyl ureas
10/11/2000EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids
10/11/2000EP1043331A1 Bone-resorptive cytokine inhibitor containing dienogest as the active ingredient
10/11/2000EP1043328A1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof
10/11/2000EP1043327A1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043318A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
10/11/2000EP1043317A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
10/11/2000EP1043316A2 Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043310A1 Biphenylamidine derivatives
10/11/2000EP1043308A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/11/2000EP1043031A1 Sustained release medicinal compositions
10/11/2000EP1043030A1 Sustained release medicinal compositions
10/11/2000EP1043025A2 Renal cell carcinoma treatment
10/11/2000EP1043022A1 Sodium ion absorption inhibitors, sodium ion excretion accelerators, and preventive and therapeutic agents for diseases resulting from excessive intake of common salt
10/11/2000EP1043021A1 Type 2 helper t cell-selective immune response suppressors
10/11/2000EP1043020A1 Medicinal composition for percutaneous administration
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042509A1 Methods of using oligonucleotide arrays to search for new kinase inhibitors
10/11/2000EP1042485A2 Desaturase
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
10/11/2000EP1042354A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
10/11/2000EP1042353A1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
10/11/2000EP1042352A1 Androgenic steroid compounds and a method of making and using the same
10/11/2000EP1042350A1 Inducible phosphofructokinase and the warburg effect
10/11/2000EP1042349A1 Using polyamide nucleic acid oligomers to engender a biological response
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042347A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042341A1 Nucleoside analog compositions and uses thereof
10/11/2000EP1042340A1 6-o-alkyl erythromycin b oxime
10/11/2000EP1042339A2 Carbohydrates, useful in solid delivery systems
10/11/2000EP1042335A1 Vitamin d derivatives with phosphorous atoms in the side chains
10/11/2000EP1042334A1 Beta-lactamase and dd-peptidase inhibitors
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042328A1 Sarcodictyin and eleutherobin derivatives useful for stabilising microtubles
10/11/2000EP1042327A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
10/11/2000EP1042326A1 Novel acronycine derivatives, preparation method and pharmaceutical compositions
10/11/2000EP1042325A1 Nitrogen-containing heterocyclic compounds, their production and use
10/11/2000EP1042324A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
10/11/2000EP1042323A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
10/11/2000EP1042322A1 Kv2.1 ANTAGONISTS
10/11/2000EP1042321A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042319A1 Dihydrobenzofurans
10/11/2000EP1042318A1 Process for the preparation of paroxetine hydrochloride
10/11/2000EP1042317A1 New pharmaceutically active compounds
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042314A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042310A2 Method for the preparation of citalopram
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042304A1 Triazine compounds for treatment of cns disorders
10/11/2000EP1042301A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
1 ... 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 ... 7860